Jul 132017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– UK, London – NightstaRx Limited a clinical-stage gene therapy company developing treatments for inherited retinal diseases, today announced that the company has appointed industry finance veteran David Lubner to its board of directors.… => Read more

NightstaRx welcomes David Lubner to the Board of Directors and its Audit Committe

From:: NightstaRx welcomes David Lubner to the Board of Directors and its Audit Committe

Sorry, the comment form is closed at this time.

%d bloggers like this: